Neisseria Meningitidis Completed Phase 3 Trials for Streptococcus pneumoniae type 19f capsular polysaccharide antigen (DB10336)

IndicationStatusPhase
DBCOND0030896 (Neisseria Meningitidis)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01553279Immunogenicity and Safety of V419 (PR51) in Combination With MCC in Infants and Toddlers (V419-011)Prevention
NCT01978093Immunogenicity, Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals' Hib-MenCY-TT (MenHibrix®) Vaccine Compared to Merck & Co, Inc. PedvaxHIB Vaccine in Healthy Infants and Toddlers 12 to 15 Months of AgePrevention